Elizabeth Balbin: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
m (Text replacement - "|last2=|first2=|authorlink2=|date" to "|date")
m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author")
Line 3: Line 3:


==Research studies==
==Research studies==
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015">{{Citation
*2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome<ref name="KlimasNG, 2015">{{Citation |last1  = Klimas |first           1  |authorlink1 = Nancy Klimas |last2  = Ironson |first           2  |authorlink2 = |last3  = Carter |first           3  |authorlink3 = |last4  = Balbin |first           4  |authorlink4 = Elizabeth Balbin |last5  = Bateman |first           5  |authorlink5 = Lucinda Bateman |last6  = Felsenstein |first       6  |authorlink6 = Donna Felsenstein |last7  = Levine |first           7  |authorlink7 = Susan Levine |last8  = Peterson |first         8  |authorlink8 = Daniel Peterson |last9  = Chiu |first             9  |authorlink9 = |last10  = Allen |first             10  |authorlink10 = |last11  = Cunningham |first       11  |authorlink11 = |last12  = Gottschalk |first       12  |authorlink12 = Gunnar Gottschalk |last13  = Fletcher |first         13  |authorlink13 = Mary Ann Fletcher |last14  = Hornig |first           14  |authorlink14 = Mady Hornig |last15  = Canning |first           15  |authorlink15 = |last16  = Komaroff |first         16  |authorlink16 = Anthony Komaroff
| last1  = Klimas            | first1 = N.G.        | authorlink1 = Nancy Klimas
| last2  = Ironson           | first2 = G.           | authorlink2 =  
| last3  = Carter            | first3 = A.          | authorlink3 =  
| last4  = Balbin            | first4 = E.          | authorlink4 = Elizabeth Balbin
| last5  = Bateman           | first5 = L.           | authorlink5 = Lucinda Bateman
| last6  = Felsenstein      | first6 = D.          | authorlink6 = Donna Felsenstein
| last7  = Levine            | first7 = S.          | authorlink7 = Susan Levine
| last8  = Peterson          | first8 = D.          | authorlink8 = Daniel Peterson
| last9  = Chiu              | first9 = K.          | authorlink9 =
| last10  = Allen            | first10 = A.          | authorlink10 =
| last11  = Cunningham        | first11 = K.          | authorlink11 =
| last12  = Gottschalk       | first12 = C.G.       | authorlink12 = Gunnar Gottschalk
| last13  = Fletcher          | first13 = M          | authorlink13 = Mary Ann Fletcher
| last14  = Hornig            | first14 = M.          | authorlink14 = Mady Hornig
| last15  = Canning          | first15 = C.          | authorlink15 =
| last16  = Komaroff          | first16 = A.L.        | authorlink16 = Anthony Komaroff
| title  = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome
| title  = Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome
| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 3 | issue =  2| page = 75-96
| journal = Fatigue: Biomedicine, Health & Behavior  | volume = 3 | issue =  2| page = 75-96
Line 27: Line 11:
}}
}}
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)]
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)]
*2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015">{{Citation
*2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study<ref name="BatemanL, 2015">{{Citation |last1  = Bateman |first       1  |authorlink1 = Lucinda Bateman |last2  = Darakjy |first       2  |authorlink2 = |last3  = Klimas |first       3  |authorlink3 = Nancy Klimas |last4  = Peterson |first     4  |authorlink4 = Daniel Peterson |last5  = Levine |first       5  |authorlink5 = Susan Levine |last6  = Allen |first         6  |authorlink6 = |last7  = Carlson |first       7  |authorlink7 = |last8  = Balbin |first       8  |authorlink8 = Elizabeth Balbin |last9  = Gottschalk |first   9  |authorlink9 = Gunnar Gottschalk |last10  = March |first         10  |authorlink10 =  
| last1  = Bateman      | first1 = L.              | authorlink1 = Lucinda Bateman
| last2  = Darakjy      | first2 = S.              | authorlink2 =  
| last3  = Klimas        | first3 = N.              | authorlink3 = Nancy Klimas
| last4  = Peterson      | first4 = D.              | authorlink4 = Daniel Peterson
| last5  = Levine        | first5 = S.M.            | authorlink5 = Susan Levine
| last6  = Allen        | first6 = A.              | authorlink6 =  
| last7  = Carlson      | first7 = S.A.            | authorlink7 =  
| last8  = Balbin        | first8 = E.G.            | authorlink8 = Elizabeth Balbin
| last9  = Gottschalk    | first9 = G.              | authorlink9 = Gunnar Gottschalk
| last10  = March        | first10 = D.            | authorlink10 =  
| title  = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study
| title  = Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3  | issue = 1  | page = 1-15
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3  | issue = 1  | page = 1-15
Line 45: Line 19:
}}
}}
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)]
</ref> [http://www.tandfonline.com/doi/full/10.1080/21641846.2014.978109 (Abstract)]
*2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline<ref name="IllnessProgressionBMC2016">{{Citation
*2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline<ref name="IllnessProgressionBMC2016">{{Citation |last1  = Russell |first       1  |authorlink1 = |last2  = Broderick |first     2  |authorlink2 = Gordon Broderick |last3  = Taylor |first       3  |authorlink3 = Renee Taylor |last4  = Fernandes |first     4  |authorlink4 = |last5  = Harvey |first       5  |authorlink5 = Jeanna Harvey |last6  = Barnes |first       6  |authorlink6 = Zachary Barnes |last7  = Smylie |first       7  |authorlink7 = |last8  = Collado |first       8  |authorlink8 = |last9  = Balbin |first       9  |authorlink9 = Elizabeth Balbin |last10 = Katz |first         10  |authorlink10 = Ben Katz |last11 = Klimas |first       11  |authorlink11 = Nancy Klimas |last12 = Fletcher |first     12  |authorlink12 = Mary Ann Fletcher
| last1  = Russell      | first1 = Lindsey          | authorlink1 =
| last2  = Broderick    | first2 = Gordon          | authorlink2 = Gordon Broderick
| last3  = Taylor        | first3 = Renee            | authorlink3 = Renee Taylor
| last4  = Fernandes    | first4 = Henrique        | authorlink4 =
| last5  = Harvey        | first5 = Jeanna          | authorlink5 = Jeanna Harvey
| last6  = Barnes        | first6 = Zachary          | authorlink6 = Zachary Barnes
| last7  = Smylie       | first7 = AnneLiese       | authorlink7 =
| last8  = Collado      | first8 = Fanny            | authorlink8 =
| last9  = Balbin       | first9 = Elizabeth       | authorlink9 = Elizabeth Balbin
| last10 = Katz          | first10 = Ben            | authorlink10 = Ben Katz
| last11 = Klimas        | first11 = Nancy          | authorlink11 = Nancy Klimas
| last12 = Fletcher      | first12 = Mary Ann        | authorlink12 = Mary Ann Fletcher
| title  = Illness progression in chronic fatigue syndrome: a shifting immune baseline
| title  = Illness progression in chronic fatigue syndrome: a shifting immune baseline
| journal = BMC Immunology
| journal = BMC Immunology
Line 64: Line 26:
| doi = 10.1186/s12865-016-0142-3
| doi = 10.1186/s12865-016-0142-3
}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785654/ (Full Text)]
}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785654/ (Full Text)]
*2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017">{{Citation
*2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017">{{Citation |last1  = Unger |first       1  |authorlink1 = Elizabeth Unger |last2  = Lin |first         2  |authorlink2 = Jin-Mann Sally Lin |last3  = Tian |first         3  |authorlink3 = |last4  = Natelson |first     4  |authorlink4 = Benjamin Natelson |last5  = Lange |first       5  |authorlink5 = Gudrun Lange |last6  = Vu |first           6  |authorlink6 = |last7  = Blate |first       7  |authorlink7 = |last8  = Klimas |first       8  |authorlink8 = Nancy Klimas   |last9  = Balbin |first       9  |authorlink9 = Elizabeth Balbin |last10  = Bateman |first     10  |authorlink10 = Lucinda Bateman |last11  = Allen |first       11  |authorlink11 =   |last12  = Lapp |first         12  |authorlink12 = Charles Lapp |last13  = Springs |first     13  |authorlink13 =   |last14  = Kogelnik |first     14  |authorlink14 = Andreas Kogelnik |last15  = Phan |first         15  |authorlink15 =   |last16  = Danver |first       16  |authorlink16 =   |last17  = Podell |first       17  |authorlink17 = Richard Podell  
| last1  = Unger        | first1 = Elizabeth R.    | authorlink1 = Elizabeth Unger
| last18  = Fitzpatrick  | first18 = Trisha        | authorlink18 =   |last19  = Peterson |first     19  |authorlink19 = Daniel Peterson  
| last2  = Lin          | first2 = Jin-Mann S.    | authorlink2 = Jin-Mann Sally Lin
| last3  = Tian        | first3 = Hao            | authorlink3 =  
| last4  = Natelson    | first4 = Benjamin H      | authorlink4 = Benjamin Natelson  
| last5  = Lange        | first5 = Gudrun          | authorlink5 = Gudrun Lange
| last6  = Vu           | first6 = Diana           | authorlink6 =  
| last7  = Blate       | first7 = Michelle       | authorlink7 =  
| last8  = Klimas      | first8 = Nancy G.        | authorlink8 = Nancy Klimas
| last9  = Balbin      | first9 = Elizabeth G.    | authorlink9 = Elizabeth Balbin  
| last10  = Bateman      | first10 = Lucinda        | authorlink10 = Lucinda Bateman  
| last11  = Allen        | first11 = Ali            | authorlink11 =
| last12  = Lapp        | first12 = Charles W.    | authorlink12 = Charles Lapp  
| last13  = Springs      | first13 = Wendy          | authorlink13 =
| last14  = Kogelnik     | first14 = Andreas M.     | authorlink14 = Andreas Kogelnik  
| last15  = Phan        | first15 = Catrina C.    | authorlink15 =
| last16  = Danver      | first16 = Joan          | authorlink16 =
| last17  = Podell      | first17 = Richard N.    | authorlink17 = Richard Podell  
| last18  = Fitzpatrick  | first18 = Trisha        | authorlink18 =
| last19  = Peterson    | first19 = Daniel L.      | authorlink19 = Daniel Peterson  
| last20  = Gottschalk  | first20 = C. Gunnar      | authorlink20 = Gunnar Gottschalk
| last20  = Gottschalk  | first20 = C. Gunnar      | authorlink20 = Gunnar Gottschalk
| last21  = Rajeevan    | first21 = Mangalathu S.  | authorlink21 = Mangalathu Rajeevan
| last21  = Rajeevan    | first21 = Mangalathu S.  | authorlink21 = Mangalathu Rajeevan

Revision as of 05:17, May 11, 2022

Elizabeth Balbin.png

Elizabeth G. Balbin, MSc, is Clinical Research Director at the Institute for Neuro-Immune Medicine at Nova Southeastern University (NSU) in Florida.[1]

Research studies[edit | edit source]

  • 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[2] (Abstract)
  • 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[3] (Abstract)
  • 2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline[4] (Full Text)
  • 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[5] (Full Text)
  • 2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome[6] (Abstract)

Online presence[edit | edit source]

References[edit | edit source]

  1. ↑ NSU. "Our Team | Clinical Research | NSU Institute for Neuro Immune Medicine". NSU. Nova Southeastern University. Retrieved January 11, 2019.
  2. ↑ 1first 2 first 1 first 3 first 2, "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome" 
  3. ↑ 1first 2 first 1 first 3 first 2, "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study" 
  4. ↑ 1first 2 first 1 first 3 first 2, "Illness progression in chronic fatigue syndrome: a shifting immune baseline" 
  5. ↑ 1first 2 first 1 first 3 first 2, "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study." 
  6. ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Elizabeth_Balbin&oldid=110521"